Login
$BIIB
$252.26 +$1.57 (0.63%) Close

$BIIB 4 SEC Filings

Filed On Filing
05 Oct 2026 Form 4: Godbout Sean, Chief Accounting Officer

Granted 985 Restricted Stock Unit · Received 27 shares by exercise or conversion · Gave up 8 shares to cover exercise price or tax ($1.76K)

03 Sep 2026 Form 4: Parini Michael, Chief Legal Officer

Granted 7,405 Restricted Stock Unit

05 Aug 2026 Form 4: Minor Lloyd, Director

Sold 593 shares ($121K) · Sold 593 shares ($119K)

11 Jun 2026 Form 4: Hawkins William A, Director

Received 1,505 shares as a grant or award

11 Jun 2026 Form 4: Sherwin Stephen A, Director

Received 1,505 shares as a grant or award

11 Jun 2026 Form 4: Rowinsky Eric K, Director

Received 1,505 shares as a grant or award

11 Jun 2026 Form 4: Mantas Jesus B, Director

Received 1,505 shares as a grant or award

11 Jun 2026 Form 4: Langer Susan, Director

Received 1,505 shares as a grant or award

11 Jun 2026 Form 4: Patolawala Monish D, Director

Received 1,505 shares as a grant or award

11 Jun 2026 Form 4: Pangalos Menelas N, Director

Received 2,370 shares by exercise or conversion · Received 1,505 shares as a grant or award

11 Jun 2026 Form 4: Minor Lloyd, Director

Received 1,505 shares as a grant or award

11 Jun 2026 Form 4: Freire Maria C, Director

Received 2,005 shares as a grant or award

05 May 2026 Form 4: Keeney Adam, Head of Corporate Development

Received 939 shares by exercise or conversion · Gave up 455 shares to cover exercise price or tax ($85.1K)

03 Apr 2026 Form 4: Godbout Sean, Chief Accounting Officer

Received 181 shares by exercise or conversion · Gave up 54 shares to cover exercise price or tax ($9.92K)

17 Feb 2026 Form 4: Viehbacher Christopher, Director

Granted 38,015 Restricted Stock Unit

17 Feb 2026 Form 4: Singhal Priya, Head of Development

Granted 10,560 Restricted Stock Unit

17 Feb 2026 Form 4: Murphy Nicole, Head of Pharm Ops and Tech

Bought 3 shares ($585) · Granted 10,560 Restricted Stock Unit

17 Feb 2026 Form 4: Kramer Robin, Chief Financial Officer

Granted 8,450 Restricted Stock Unit

17 Feb 2026 Form 4: Keeney Adam, Head of Corporate Development

Granted 8,025 Restricted Stock Unit

17 Feb 2026 Form 4: Izzar Rachid, Head of Global Product Strat.

Granted 7,390 Restricted Stock Unit

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support